Feel Comfortable Using Chantix in Patients With STABLE Psychiatric Conditions

February 2017

Boxed warnings about psychiatric events will be REMOVED from Chantix (varenicline) and bupropion labeling for smoking cessation.

These warnings about mood changes, agitation, nightmares, and other psychiatric risks were originally added based on case reports.

Now a large trial suggests that these meds do NOT increase psychiatric side effects in patients quitting smoking.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote